Kimberlie Cerrone

Kimberlie Cerrone
Kimberlie Cerrone

Kimberlie Cerrone

UNITED STATES

Chief Executive Officer of Tiatros, Inc.

Kimberlie L. Cerrone has extensive venture, operations, management, strategic planning, deal-making and international business and legal experience, including over twenty-five years experience in structuring and executing many types of strategic alliances, joint ventures, mergers and acquisitions and partner, licensing, customer and vendor relationships for life science and high technology companies. She is expert in developing and executing intellectual property protection strategies and in acquiring, managing and exploiting valuable intellectual property, and technology and product rights

Kimberlie has significant startup, industry, venture and major law firm experience. In 1987, she co-founded Neurobiological Technologies, Inc. Kimberlie led this biotechnology company's business development, regulatory affairs and financing efforts for its first three years, and served on its Board of Directors prior to its initial public offering in 1994. She has served as Chief Financial Officer or General Counsel at seven venture capital-backed companies; two of which she saw from the initial startup phase through public offerings and beyond. She is a licensed California and patent attorney who practiced licensing law from 1994 to 1998 at Gunderson Dettmer and Venture Law Group where her practice emphasized high technology and life sciences companies, including Yahoo!, Ariba and Target Therapeutics. Kimberlie was the Managing Member of The Angels Forum, a group of early-stage equity investors, and the Managing Partner of The Halo Fund and The Halo Fund II, early-stage venture capital funds headquartered in Palo Alto, California.

Several venture capital firms regularly introduce Kimberlie to their early stage portfolio companies. She often joins these companies as an executive, consultant or advisor in order to help them establish intellectual property portfolios, perfect their distribution, sales and licensing strategies, establish legal and financial methodologies, and execute their early strategic, international, vendor and customer deals.

Kimberlie graduated from the University of Illinois where she was recognized as an Edmund James Scholar. She earned a Master of Science degree in biochemical pharmacology from New York University. She was awarded a Master of Business Administration degree from University of San Francisco and was admitted to the National Beta Gamma Sigma Society. She graduated from the University of California, Hastings College of the Law. Kimberlie is admitted to practice patent law before the United States Patent and Trademark Office.

Kimberlie serves on several business advisory boards of both high tech and life science companies, and is a director or trustee of several for profit and nonprofit organizations. She is currently consulting to a few Fortune 500 companies as well as advising several venture-backed startup companies. She has authored several articles and book chapters on business strategies that maximize the strategic value of intellectual property and is frequently invited to speak around the world at business and venture capital conferences.